Food restriction alters N′-propyl-4,5,6,7-tetrahydrobenzothiazole-2, 6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: Evidence for sensitization of dopamine D2 receptor-mediated effects

Journal of Pharmacology and Experimental Therapeutics

Volumn 325, Issue 2, 2008, Pages 691-697

  Collins, Gregory T ^a   Calinski, Diane M ^a   Newman, Amy Hauck ^b   Grundt, Peter ^b   Woods, James H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 (4 CHLOROPHENYL) 4 HYDROXYPIPERIDIN L YL]METHYL 1H INDOLE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; L 741626; PRAMIPEXOLE; UNCLASSIFIED DRUG; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE; BENZAMIDE DERIVATIVE; BENZOTHIAZOLE DERIVATIVE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; INDOLE DERIVATIVE; N (4 (4 (2,3 DICHLOROPHENYL)PIPERAZIN 1 YL)BUT 2 ENYL) 4 PYRIDINE 2 YLBENZAMIDE; N-(4-(4-(2,3-DICHLOROPHENYL)PIPERAZIN-1-YL)BUT-2-ENYL)-4-PYRIDINE-2-YLBENZAMIDE; PHYSOSTIGMINE; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; PRAMIPEXOL; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET; DIET RESTRICTION; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG RESPONSE; DRUG SENSITIZATION; HYPOTHERMIA; LOCOMOTION; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RAT; YAWNING; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG POTENTIATION; FOOD; MOTOR ACTIVITY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BENZAMIDES; BENZOTHIAZOLES; DOPAMINE AGONISTS; FOOD; HYPOTHERMIA; INDOLES; MALE; MOTOR ACTIVITY; PENILE ERECTION; PHYSOSTIGMINE; PIPERAZINES; PIPERIDINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; YAWNING;

EID: 42449092037     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.133181     Document Type: Article

References (40)

1. Alberto CO, Trask RB, Quinlan ME, and Hirasawa M (2006) Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons. J Neurosci 26:10043-10050.
2. Argiolas A and Melis MR (1998) The neuropharmacology of yawning. Eur J Pharmacol 343:1-16.
3. Boulay D, Depoortere R, Perrault G, Borrelli E, and Sanger DJ (1999) Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. Neuropharmacology 38:1389-1396.
4. Cadoni C, Solinas M, Valentini V, and Di Chiara G (2003) Selective psychostimulant sensitization by food restriction: differential changes in accumbens shell and core dopamine. Eur J Neurosci 18:2326-2334.
5. Carlson JN, Glick SD, Hinds PA, and Baird JL (1988) Food deprivation alters dopamine utilization in the rat prefrontal cortex and asymmetrically alters amphetamine-induced rotational behavior. Brain Res 454:373-377.
6. Carr KD, Kim GY, and Cabeza de Vaca S (2001) Rewarding and locomotor-activating effects of direct dopamine receptor agonists are augmented by chronic food restriction in rats. Psychopharmacology (Berl) 154:420-428.
7. Carr KD, Tsimberg Y, Berman Y, and Yamamoto N (2003) Evidence of increased dopamine receptor signaling in food-restricted rats. Neuroscience 119:1157-1167.
8. Carroll ME, France CP, and Meisch RA (1979) Food deprivation increases oral and intravenous drug intake in rats. Science 205:319-321.
9. Carroll ME, France CP, and Meisch RA (1981) Intravenous self-administration of etonitazene, cocaine and phencyclidine in rats during food deprivation and satiation. J Pharmacol Exp Ther 217:241-247.
10. Chaperon F, Tricklebank MD, Unger L, and Neijt HC (2003) Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors. Neuropharmacology 44:1047-1053.
11. Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, and Woods JH (2005) Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior. J Pharmacol Exp Ther 314:310-319.
12. Collins GT, Newman AH, Grundt P, Rice KC, Husbands SM, Chauvignac C, Chen J, Wang S, and Woods JH (2007) Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology (Berl) 193:159-170.
13. Deroche V, Piazza PV, Casolini P, Le Moal M, and Simon H (1993) Sensitization to the psychomotor effects of amphetamine and morphine induced by food restriction depends on corticosterone secretion. Brain Res 611:352-356.
14. Donny EC, Caggiula AR, Mielke MM, Jacobs KS, Rose C, and Sved AF (1998) Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology (Berl) 136:83-90.
15. Faunt JE and Crocker AD (1987) The effects of selective dopamine receptor agonists and antagonists on body temperature in rats. Eur J Pharmacol 133:243-247.
16. Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, and Newman AH (2005) Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. J Med Chem 48:839-848.
17. Grundt P, Prevatt KM, Cao J, Taylor M, Floresca CZ, Choi JK, Jenkins BG, Luedtke RR, and Newman AH (2007) Heterocyclic analogues of N-(4-(4-(2,3- dichlorophenyl) piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. J Med Chem 50:4135-4146.
18. Gur E, Newman ME, Avraham Y, Dremencov E, and Berry EM (2003) The differential effects of food restriction on 5-HT1A and 5-HT1B receptor mediated control of serotonergic transmission in the hippocampus and hypothalamus of rats. Nutr Neurosci 6:169-175.
19. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
20. Isaac SO and Berridge CW (2003) Wake-promoting actions of dopamine D1 and D2 receptor stimulation. J Pharmacol Exp Ther 307:386-394.
21. Jahng JW, Kim JG, Kim HJ, Kim BT, Kang DW, and Lee JH (2007) Chronic food restriction in young rats results in depression- and anxiety-like behaviors with decreased expression of serotonin reuptake transporter. Brain Res 1150:100-107.
22. Kelley AE, Baldo BA, Pratt WE, and Will MJ (2005) Corticostriatal- hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol Behav 86:773-795.
23. Leibowitz SF, Weiss GF, and Suh JS (1990) Medial hypothalamic nuclei mediate serotonin's inhibitory effect on feeding behavior. Pharmacol Biochem Behav 37:735-742.
24. Leibowitz SF and Alexander JT (1998) Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 44:851-864.
25. Levant B (1997) The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49:231-252.
26. Lin MT, Chandra A, Tsay BL, and Chern YF (1982) Hypothalamic and striatal dopamine receptor activation inhibits heat production in the rat. Am J Physiol Regul Integr Comp Physiol 242:R471-R481.
27. Macenski MJ and Meisch RA (1999) Cocaine self-administration under conditions of restricted and unrestricted food access. Exp Clin Psychopharmacol 7:324-337.
28. Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A, and Rossi-Fanelli F (2000) Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 16:843-857.
29. Meisch RA and Thompson T (1973) Ethanol as a reinforcer: effects of fixed-ratio size and food deprivation. Psychopharmacologia 28:171-183.
30. Melis MR, Argiolas A, and Gessa GL (1987) Apomorphine-induced penile erection and yawning: site of action in brain. Brain Res 415:98-104.
31. Millan MJ, Gobert A, Newman-Tancredi A, Lejeune F, Cussac D, Rivet JM, Audinot V, Dubuffet T, and Lavielle G (2000) S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626. J Pharmacol Exp Ther 293:1048-1062.
32. Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, and Newman-Tancredi A (2002) Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther 303:791-804.
33. Nasello AG, Tieppo CA, and Felicio LF (1995) Apomorphine-induced yawning in the rat: influence of fasting and time of day. Physiol Behav 57:967-971.
34. Ouagazzal AM and Creese I (2000) Intra-accumbens infusion of D(3) receptor agonists reduces spontaneous and dopamine-induced locomotion. Pharmacol Biochem Behav 67:637-645.
35. Palmiter RD (2007) Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 30:375-381.
36. Persinger MA, Stewart LS, Richards PM, Harrigan T, O'Connor RP, and Bureau YR (2002) Seizure onset times for rats receiving systemic lithium and pilocarpine: sources of variability. Pharmacol Biochem Behav 71:7-17.
37. Pothos EN, Creese I, and Hoebel BG (1995) Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J Neurosci 15:6640-6650.
38. Robinson TE and Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291.
39. Svensson K, Carlsson A, and Waters N (1994) Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J Neural Transm Gen Sect 95:71-74.
40. Yamada K, Tanaka M, Shibata K, and Furukawa T (1986) Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats. Psychopharmacology (Berl) 90:9-13.